Valion Bio, Inc. Common Stock (NASDAQ:VBIO) versus CVR Medical (OTCMKTS:CRRVF) Critical Contrast

Valion Bio, Inc. Common Stock (NASDAQ:VBIO) and CVR Medical (OTCMKTS:CRRVF) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

Profitability

This table compares Valion Bio, Inc. Common Stock and CVR Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Valion Bio, Inc. Common Stock	N/A	-138.10%	-63.67%
CVR Medical	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent recommendations for Valion Bio, Inc. Common Stock and CVR Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Valion Bio, Inc. Common Stock	1	0	0	0	1.00
CVR Medical	0	0	0	0	0.00

Given CVR Medical’s higher probable upside, analysts plainly believe CVR Medical is more favorable than Valion Bio, Inc. Common Stock.

Volatility & Risk

Valion Bio, Inc. Common Stock has a beta of 1.86, suggesting that its stock price is 86% more volatile than the S&P 500. Comparatively, CVR Medical has a beta of 32.6, suggesting that its stock price is 3,160% more volatile than the S&P 500.

Valuation and Earnings

This table compares Valion Bio, Inc. Common Stock and CVR Medical”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Valion Bio, Inc. Common Stock	$780,000.00	3.61	-$8.88 million	($6.68)	-0.13
CVR Medical	N/A	N/A	N/A	($0.02)	N/A

CVR Medical has lower revenue, but higher earnings than Valion Bio, Inc. Common Stock. Valion Bio, Inc. Common Stock is trading at a lower price-to-earnings ratio than CVR Medical, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

4.3% of Valion Bio, Inc. Common Stock shares are held by institutional investors. 14.5% of Valion Bio, Inc. Common Stock shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

CVR Medical beats Valion Bio, Inc. Common Stock on 5 of the 9 factors compared between the two stocks.

About Valion Bio, Inc. Common Stock

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

About CVR Medical

CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.